KINETIC-MODELS OF INDUCTION .1. PERSISTENCE OF THE INDUCING SUBSTANCE

[1] ABRAMSON FP, 1986, DRUG METAB DISPOS, V14, P46

[2] RELATIONSHIPS BETWEEN PROPRANOLOL PLASMA-PROTEIN BINDING, GLYCOPROTEIN CONCENTRATION, AND ENZYME-INDUCTION FOLLOWING PHENOBARBITAL ADMINISTRATION IN THE DOG [J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (17) : 2618 - 2620

[3] ARIAS IM, 1967, MOL PHARM, V3, P215

[4] BAI SA, 1982, J PHARMACOL EXP THER, V222, P589

[5] BERLIN CM, 1965, MOL PHARMACOL, V1, P149

[6] BUSCH U, 1981, ARZNEIMITTEL-FORSCH, V31-1, P204

[7] CAMERON BD, 1981, ARZNEIMITTEL-FORSCH, V31-1, P217

[8] DEBRUIN A, 1976, BIOCH TOXICOLOGY ENV, P174

[9] TIME COURSE OF PHENOBARBITAL AND CIMETIDINE MEDIATED CHANGES IN HEPATIC DRUG-METABOLISM [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (02) : 215 - 222

[10] EFFECT OF PHENOBARBITAL ADMINISTRATION TO RATS ON THE LEVEL OF THE INVITRO SYNTHESIS OF CYTOCHROME-P-450 DIRECTED BY TOTAL RAT-LIVER RNA [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 90 (01) : 150 - 157

[1] ABRAMSON FP, 1986, DRUG METAB DISPOS, V14, P46

[2] RELATIONSHIPS BETWEEN PROPRANOLOL PLASMA-PROTEIN BINDING, GLYCOPROTEIN CONCENTRATION, AND ENZYME-INDUCTION FOLLOWING PHENOBARBITAL ADMINISTRATION IN THE DOG [J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (17) : 2618 - 2620

[3] ARIAS IM, 1967, MOL PHARM, V3, P215

[4] BAI SA, 1982, J PHARMACOL EXP THER, V222, P589

[5] BERLIN CM, 1965, MOL PHARMACOL, V1, P149

[6] BUSCH U, 1981, ARZNEIMITTEL-FORSCH, V31-1, P204

[7] CAMERON BD, 1981, ARZNEIMITTEL-FORSCH, V31-1, P217

[8] DEBRUIN A, 1976, BIOCH TOXICOLOGY ENV, P174

[9] TIME COURSE OF PHENOBARBITAL AND CIMETIDINE MEDIATED CHANGES IN HEPATIC DRUG-METABOLISM [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (02) : 215 - 222

[10] EFFECT OF PHENOBARBITAL ADMINISTRATION TO RATS ON THE LEVEL OF THE INVITRO SYNTHESIS OF CYTOCHROME-P-450 DIRECTED BY TOTAL RAT-LIVER RNA [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 90 (01) : 150 - 157